Table 3.
Pt | Age (years) | Height SDS | IGF-1 SDS | Gene transcript | Translation | SIFT score | Polyphen | CADD score | ACMG/AMP classification |
---|---|---|---|---|---|---|---|---|---|
1 | 3.8 | −3.6 | −2.0 | No deleterious variants detected | N/A | N/A | N/A | N/A | N/A |
2 | 3.7 | −4.2 | −2.5 |
ACAN Het c.1223A>G, p.Q532H |
Missense | Damaging | Probably damaging |
23.7 | Uncertain significance |
3 | 2.6 | −3.8 | −2.3 | No DNA available | N/A | N/A | N/A | N/A | N/A |
4 | 2.8 | −3.1 | −2.5 |
OBSL1 Het c.2671A>G, p.T891A |
Missense | Damaging | Probably damaging |
26.8 | Uncertain significance |
CBL Het c.125_127dupACC, p.H42dup |
In-frame | NK | NK | 12.6 | Likely benign | ||||
5 | 5.7 | −4.5 | −2.5 |
OBSL1 Het c.2671A>G, p.T891A |
Missense | Damaging | Probably damaging |
26.8 | Uncertain significance |
6 | 1.2 | −4.4 | −2.2 |
IGF1R Het c.109_123dupATCGACATCCGCAAC, p.I37_N41dup |
In-frame | NK | NK | NK | Uncertain significance |
7 | 7.0 | −4.2 | −2.5 |
CBL Het c.2216C>T, p.S739F |
Missense | Damaging | Benign | 23.1 | Uncertain significance |
8 | 5.7 | −3.0 | −2.9 |
ACAN Het c.1596G>C, p.R132C |
Missense | Damaging | Probably damaging |
27.9 | Uncertain significance |
9 | 4.3 | −4.1 | −4.0 |
CUL7 Het c.464G>A, p.G155E c.620G>A, p.G207E |
Missense | Damaging | Probably damaging |
26.9 | Uncertain significance |
10 | 2.5 | −4.4 | NK |
IGFALS Het c.544C>A, p.L220M c.658C>A, p.L182M |
Missense | Damaging | Probably damaging |
23.5 | Uncertain significance |
11 | 5.7 | −4.7 | −3.1 | No deleterious variants detected | N/A | N/A | N/A | N/A | N/A |
12 | 9.9 | −5.1 | −2.1 | No deleterious variants detected | N/A | N/A | N/A | N/A | N/A |
Patients 1–4 are the 6Ψ patients analysed for WT-GHR and 6Ψ-GHR transcript ratios (Table 2).
ACMG/AMP classification, classification as per the American College of Medical Genetics and Genomics and the Association for Molecular Pathology’s standards and guidelines for the interpretation of sequence variants; c., coding DNA sequence where nucleotide 1 is the A of the ATG-translation initiation codon (NCBI reference sequences: for ACAN, NM_013227.2; for OBSL1, NM_015311.2; for CBL, NM_005188.3; for IGF1R, NM_000875.3; for CUL7, NM_001168370.1 and for IGFALS, NM_004970.2); CADD, combined annotation dependent depletion; Ht, height; N/A, not applicable; NK, not known; Pt, patient (30).